Beth Israel Deaconess Med. Ctr., ACTG CRS (103) — Boston, Massachusetts

Beth Israel Deaconess Med. Ctr., ACTG CRS (103) is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Med. Ctr., ACTG CRS (103) has participated in 4 clinical trials.

Therapeutic areas: HIV Infections, HIV-1 Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Med. Ctr., ACTG CRS (103)?

Beth Israel Deaconess Med. Ctr., ACTG CRS (103) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Med. Ctr., ACTG CRS (103) conducted?

Beth Israel Deaconess Med. Ctr., ACTG CRS (103) has 4 clinical trials on record. Their work covers HIV Infections, HIV-1 Infection.

Is Beth Israel Deaconess Med. Ctr., ACTG CRS (103) accredited by Crixeo Health?

Beth Israel Deaconess Med. Ctr., ACTG CRS (103) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deaconess Med. Ctr., ACTG CRS (103)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.